Evidence map›Paper›PMID 34663503›Full record

SynthesisBiological psychiatry2022

Personality Associations With Amyloid and Tau: Results From the Baltimore Longitudinal Study of Aging and Meta-analysis.

Antonio Terracciano, Murat Bilgel, Damaris Aschwanden, Martina Luchetti, Yannick Stephan, Abhay R Moghekar, Dean F Wong, Luigi Ferrucci, Angelina R Sutin, Susan M Resnick

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Biological psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Antonio TerraccianoDepartment of Geriatrics, Florida State University College of Medicine, Tallahassee, Florida; Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland. Electronic address: antonio.terracciano@med.fsu.edu.
Murat BilgelLaboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.
Damaris AschwandenDepartment of Geriatrics, Florida State University College of Medicine, Tallahassee, Florida.
Martina LuchettiDepartment of Behavioral Sciences and Social Medicine, Florida State University College of Medicine, Tallahassee, Florida.
Yannick StephanEuromov, University of Montpellier, Montpellier, France.
Abhay R MoghekarDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Dean F WongDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Luigi FerrucciLaboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.
Angelina R SutinDepartment of Behavioral Sciences and Social Medicine, Florida State University College of Medicine, Tallahassee, Florida.
Susan M ResnickLaboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland.
Florida State University · USNational Institutes of Health · USJohns Hopkins University · USUniversité de Montpellier · FRWashington University in St. Louis · US

Funding

The Baltimore Longitudinal Study Of AgingZIAAG000015 · NIA · NATIONAL INSTITUTE ON AGING · PI SIMONSICK, ELEANOR MARIE · 2009 to 2025
$116.9M
Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
Neuroimaging Predictors of Cognitive Decline, Impairment, and ResilienceZIAAG000191 · NIA · NATIONAL INSTITUTE ON AGING · PI FERRUCCI, LUIGI · 2009 to 2025
$26.4M
Early Markers of Alzheimer DiseaseZIAAG000185 · NIA · NATIONAL INSTITUTE ON AGING · PI WALKER, KEENAN · 2009 to 2025
$20.4M
Tau PET in BLSA Participants: An Alzheimer's Disease BiomarkerZIAAG000341 · NIA · NATIONAL INSTITUTE ON AGING · PI RESNICK, SUSAN · 2017 to 2024
$6.7M
Prenatal and Early Life Antecedents of Personality: An Intergenerational Lifespan ApproachR01AG053297 · NIA · FLORIDA STATE UNIVERSITY · PI Angelina R Sutin · 2017 to 2026
$4.3M
Personality and Dementia: Mechanisms and TrajectoriesR01AG068093 · NIA · FLORIDA STATE UNIVERSITY · PI TERRACCIANO, ANTONIO · 2020 to 2024
$3.0M
NIA NIH HHS P30 AG066507NIA NIH HHS R01 AG053297NIA NIH HHS R01 AG068093
6 · The paper itself

Abstract

backgroundHigher neuroticism and lower conscientiousness are risk factors for Alzheimer's disease and related dementias, but the underlying neuropathological correlates remain unclear. Our aim was to examine whether personality traits are associated with amyloid and tau neuropathology in a new sample and meta-analyses.

methodsParticipants from the BLSA (Baltimore Longitudinal Study of Aging) completed the Revised NEO Personality Inventory and underwent amyloid (

resultsAmong cognitively normal BLSA participants, neuroticism was associated with higher cortical amyloid burden (odds ratio 1.68, 95% CI 1.20-2.34), and conscientiousness was associated with lower cortical amyloid burden (odds ratio 0.61, 95% CI 0.44-0.86). These associations remained significant after accounting for age, sex, education, depressive symptoms, hippocampal volume, and APOE ε4. Similar associations were found with tau in the entorhinal cortex. Random-effects meta-analyses of 12 studies found that higher neuroticism (N = 3015, r = 0.07, p = .008) and lower conscientiousness (N = 2990, r = -0.11, p < .001) were associated with more amyloid deposition. Meta-analyses of 8 studies found that higher neuroticism (N = 2231, r = 0.15, p < .001) and lower conscientiousness (N = 2206, r = -0.14, p < .001) were associated with more tau pathology. The associations were moderated by cognitive status, with stronger effects in cognitively normal compared with heterogeneous samples, suggesting that the associations between personality and proteopathies are not phenomena that emerge with neuropsychiatric clinical symptoms.

conclusionsBy aggregating results across samples, this study advances knowledge on the association between personality and neuropathology. Neuroticism and conscientiousness may contribute to resistance against amyloid and tau neuropathology.

Indexed as

Alzheimer Diseasetau ProteinsAgingAmyloid beta-PeptidesBaltimoreHumansLongitudinal StudiesPersonalityPositron-Emission TomographyAmyloid beta-Peptidestau ProteinsAlzheimer diseaseAmyloidMeta-analysisNeuropsychiatric disordersPersonalityTau

Identifiers

PMID34663503
PMCPMC8792161
OpenAlexW3197848201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.